Jia Geng

Jia Geng

Auto-generated profile, based on publicly available information

Jia Geng

Department of Otolaryngology-Head and Neck Surgery, West China Hospital, Sichuan University, Chengdu, China; Institute of Rare Diseases, West China Hospital, Sichuan University, Chengdu, China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 January 2024 in Journal of Medical Genetics
Verified
Journal Article
Open access
PDF file
XYXiaohong Yan
Xiaohong Yan
JWJing Wang
Jing Wang
WYWen Yang
Wen Yang
LLLinke Li
Linke Li
TSTian Shen
Tian Shen
HYHuijun Yuan
Huijun Yuan
Background: Townes-Brocks syndrome (TBS) is a rare genetic disorder characterised by multiple malformations. Due to its phenotypic heterogeneity and rarity, diagnosis and recognition of TBS can be challenging and there has been a lack of investigation of patients with atypical TBS in large cohorts and delineation of their phenotypic characteristics. Methods: We screened SALL1 and DACT1 variants using next-generation sequencing in the China Deafness Genetics Consortium (CDGC) cohort enrolling 20 666 unrelated hearing loss (HL) cases. Comprehensive clinical evaluations were conducted on seven members from a three-generation TBS family. Combining data from previously reported cases, we also provided a landscape of phenotypes and genotypes of patients with TBS. Results: We identified five novel and two reported pathogenic/likely pathogenic (P/LP) SALL1 variants from seven families. Audiological features in patients differed in severity and binaural asymmetry. Moreover, previously undocumented malformations in the middle and inner ear were detected in one patient. By comprehensive clinical evaluations, we further provide evidence for the causal relationship between SALL1 variation and certain endocrine abnormalities. Penetrance analysis within familial contexts revealed incomplete penetrance among first-generation patients with TBS and a higher disease burden among their affected offspring. Conclusion: This study presents the first insight of genetic screening for patients with TBS in a large HL cohort. We broadened the phenotypic-genotypic spectrum of TBS and our results supported an underestimated prevalence of TBS. Due to the rarity and phenotypic heterogeneity of rare diseases, broader spectrum molecular tests, especially whole genome sequencing, can improve the situation of underdiagnosis and provide effective recommendations for clinical management.

17 October 2025 in Science Advances
Verified
Journal Article
Open access
YHYuguo Huang
Yuguo Huang
MWMengge Wang
Mengge Wang
ZWZhiyong Wang
Zhiyong Wang
XLXiaojun Liu
Xiaojun Liu
YFYuhang Feng
Yuhang Feng
HYHuijun Yuan
Huijun Yuan
Short tandem repeats (STRs) confer evolutionary advantages across various species, yet their roles in human high-altitude adaptation remain largely unexplored. In this study, we analyzed over 1.1 million STRs in 7876 whole-genome sequencing samples, including 3808 newly sequenced Tibeto-Burman (TB) speakers and Han Chinese individuals inhabiting the Qinghai-Tibet Plateau and neighboring regions. We characterized more than 570,000 polymorphic STRs across coding/noncoding genomic and functional contexts, revealing distinct STR variation patterns specific to TB speakers. Notably, divergent STRs in TB speakers were predominantly located in high-altitude adaptive genes and frequently associated with gene expression levels. Additionally, we identified over 17,000 STRs strongly associated with environmental conditions on the Qinghai-Tibet Plateau. These STRs exerted multilevel gene regulation through modulating protein coding, fine-tuning cis-regulatory elements, and modulating biological pathways. Furthermore, we observed substantial contributions of functional and adaptive STRs to human phenotypic diversity. Collectively, our findings provide genomic STR resources of TB speakers and genetic insights into their roles in human adaptive evolution.

16 January 2021 in Molecular Genetics & Genomic Medicine
Verified
Journal Article
Open access
PDF file
JGJia Geng
Jia Geng
YSYi Sun
Yi Sun
YZYi Zhao
Yi Zhao
WXWenyu Xiong
Wenyu Xiong
MZMingjun Zhong
Mingjun Zhong
HYHuijun Yuan
Huijun Yuan
Background: Biotinidase deficiency (OMIM 253260) is an autosomal recessively inherited disorder affecting about 1/60,000 people worldwide. The absence or deficiency of biotinidase impairs free biotin recycling and affects biotin‐dependent carboxylase functions.Methods: A Chinese patient with spontaneous recurrent epilepsy, an eczema‐like rash, hair loss, hypotonia, and hearing loss began at three months of age. Her biotinidase activity was 1.0 nmol/ml/min, 9.5% of the mean control activity, which confirmed profound biotinidase deficiency.Results: Compound heterozygous for c.250‐1G > C and c.878dupT variants in the BTD gene were identified in this patient. These two variants were novel and absent in the population matched controls and any databases.Conclusions: This study expanded the mutation spectrum of alterations of the BTD gene. Our patient also emphasized the critical role of biotinidase activity measurement combined with mutation analysis in early diagnosis of biotinidase deficiency.

1 January 2026 in Human Mutation
Verified
Journal Article
Open access
DLDongmei Li
Dongmei Li
WPWan Peng
Wan Peng
LKLu Kang
Lu Kang
JGJia Geng
Jia Geng
YLYu Lu
Yu Lu
JLJing Lu
Jing Lu
X‐linked hypophosphatemia (XLH), primarily caused by mutations of the PHEX gene, is the most common cause of genetic rickets. Pediatric cases of XLH typically present with elevated levels of serum fibroblast growth factor 23 (FGF23), hypophosphatemia, rickets, and impaired growth. Here, we report a 2‐year‐old boy diagnosed with XLH, presenting with short stature, genu varum, and hypophosphatemia. Sanger sequencing revealed a novel mutation of the PHEX gene, comprising a 62‐bp poly‐T and a 421‐bp long interspersed element‐1 (LINE‐1) insertion into exon 22, which appears to induce the hypophosphatemia. This study presents the first documented case of XLH associated with a partial LINE‐1 insertion in PHEX . We suggest that LINE‐1 transposon element insertions be considered in XLH patients lacking other known mutations.

30 May 2026 in EBioMedicine
Verified
Journal Article
Open access
JGJia Geng
Jia Geng
YZYixin Zhao
Yixin Zhao
YHYu Huang
Yu Huang
WXWenyu Xiong
Wenyu Xiong
MZMingjun Zhong
Mingjun Zhong
HYHuijun Yuan
Huijun Yuan
Standardised variant interpretation frameworks inadequately accommodate the distinct mutational and phenotypic architectures inherent to specific genes or diseases. POU3F4 exemplifies this limitation in X-linked hearing loss, where stringent genotype-phenotype correlations and localised mutational hotspots dominate the pathogenic landscape. We sought to establish a calibrated, gene-specific evidentiary model to resolve interpretive inconsistencies for POU3F4. We sequenced 20,666 unrelated individuals with hearing loss and 7,258 controls using targeted panel and genome sequencing to capture single-nucleotide, indel, and structural variants in POU3F4. By integrating clinical phenotyping, paralog-based residue constraint modelling, and Bayesian likelihood-ratio analysis, we redefined evidence criteria for this gene. Representative stop-loss alleles underwent functional characterisation to elucidate their molecular consequences. Genomic analysis identified 123 distinct POU3F4 variants, 87 of which were classified as pathogenic (P) or likely pathogenic (LP). Structural variants accounted for 29 of these P/LP variants, with breakpoints enriched in repeat-dense sequence across the locus. Incomplete partition type III cochlear malformation showed near-diagnostic coupling to POU3F4, with 96.4% of affected cases carrying P/LP variants, supporting escalation of PP4 to strong evidence. P/LP missense variants were significantly concentrated at paralog-conserved residues, and Bayesian modelling of this constraint produced a positive likelihood ratio of 33.0 (95% confidence interval 10.68-102.28), consistent with moderate-strength hotspot evidence of PM1. Applying the calibrated rules reclassified 17 single nucleotide variants or small indels and resolved 16 of 34 variants of uncertain significance. Functional assays demonstrated that stop-loss variants generate hydrophobic C-terminal extensions that destabilise POU3F4, driving nuclear depletion and loss of transcriptional activity. Enforced nuclear targeting restored localisation but not transcription, implicating protein instability rather than impaired nuclear import as the dominant mechanism. POU3F4 pathogenicity is defined by a highly specific cochlear signature and profound topological constraint. Quantitative calibration of these features substantially refines diagnostic resolution in POU3F4-mediated hearing loss. The convergence of genomic modelling and functional validation establishes a calibrated evidentiary framework for consistent variant classification. This work was supported by National Natural Science Foundation of China (82530036, 82471889, 82171836), National Key Research and Development Program of China (2024YFC3405704), West China Hospital, Sichuan University 1.3.5 Project for Disciplines of Excellence grant ZYJC20002, Sichuan Provincial Natural Science Foundation (2024NSFSC0648).